Register to receive a free US Cardiac Surgery and Heart Valve Device Market report synopsis and brochure

The Valcare Medical (Herzliya Pituach, Israel) Amend Mitral Valve Repair annuloplasty ring is a “D” shaped device designed to repair the mitral valve and thereby reduce valvular incompetence. The device is delivered via a sub-xiphoid transapical approach with the aid of a delivery catheter inserted through the chest and into the heart under fluoroscopic and echo guidance. The D-shaped ring is then deployed and positioned to match the annulus of the original valve.

A special mechanism provides control for moving and shaping the ring by modifying its geometry. Using a series of remotely activated mechanisms, the complete ring shape is achieved and a series of anchors in four different zones that are independently deployed attach the ring into the annulus. During the implantation procedure, the septal lateral dimension is reduced to achieve better lea¬flet coaptation, thereby reducing or eliminating the mitral regurgitation.

“Valcare’s novel technology is a pioneering breakthrough for the treatment of mitral valve regurgitation, and could be a base for additional modalities for treatment of other valve disorders,” said Uri Geiger, chairman of the board Valcare. “The team is currently focusing on adapting the delivery technique to a transeptal approach allowing for deployment of the system through a puncture in the groin, as well as using the system to treat tricuspid incompetence, another extremely common problem.”

Mitral regurgitation (MR), the most common form of valvular heart disease, is a disorder of the heart in which the mitral valve does not close properly, causing regurgitation of blood from the left ventricle through the mitral valve and back into the left atrium. Patients with MR face a dilemma of whether to undergo corrective surgery early, when they might have no or few symptoms, or wait until their condition worsens, triggering the decision to proceed with surgery.

For Further Information
More on the U.S. markets for cardiac surgery and heart valve devices can be found in the 2016 edition report published by iData entitled U.S. Markets for Cardiac Surgery and Heart Valve Devices, which covers market segments for the following: tissue heart valves, mechanical heart valves, annuloplasty repair, transcatheter mitral valve repair, transcatheter heart valve implantation, on-pump coronary artery bypass, off-pump coronary artery bypass, endoscopic vessel harvesting, anastomosis assist, cardiac ablation, transmyocardial revascularization, ventricular assist, intra-aortic balloon pumps, artifical hearts, patent foramen ovale, and atrial and ventricular septal devices.

Recent reports on the markets for cardiac surgery and heart valve devices cover the U.S. and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. Register online or email us at [email protected] for a U.S. Markets for Cardiac Surgery and Heart Valve Devices report brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by State, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: